$5000 (Ins Law 5106[c]) cannot be manipulated

Understanding the $5,000 Threshold in No-Fault Arbitration Appeals

Under New York No-Fault Insurance Law, medical providers and insurers often find themselves in disputes over unpaid claims that go to arbitration. When a provider disagrees with an arbitration award, they may seek a trial de novo (a completely new trial) in court — but only if the award meets certain requirements. One crucial requirement is that the arbitration award must be for $5,000 or more under Insurance Law section 5106(c).

A recent First Department decision highlights an important limitation: providers cannot manipulate this threshold by artificially combining separate medical services or bills. This ruling reinforces the integrity of the arbitration process and prevents abuse of the appeals system. The court’s analysis also raises questions about proper jurisdiction for these cases, as discussed in our coverage of procedural issues in no-fault litigation.

The $5,000 threshold serves important policy objectives in New York’s no-fault system. By limiting full trials to disputes involving substantial amounts, the law preserves judicial resources for significant cases while relying on streamlined arbitration for smaller disputes. This two-tier system balances access to courts against efficiency concerns in a high-volume claims environment.

Understanding how courts calculate whether disputes meet the $5,000 threshold becomes critical for practitioners deciding whether to pursue arbitration appeals. The distinction between aggregating related services versus artificially bundling separate claims can determine whether parties gain access to court review.

Case Background

American Transit Insurance Co. brought a declaratory judgment action against Health Plus Surgery Center, LLC and CitiMed Services, PA seeking determinations that it owed no benefits for various medical services. The case involved a master arbitrator’s award in favor of CitiMed for an amount less than $5,000.

CitiMed apparently sought to appeal the arbitration award through a trial de novo proceeding. To meet the $5,000 jurisdictional threshold, CitiMed attempted to combine the value of separate medical services that had been billed individually. American Transit opposed this approach, arguing that the distinct nature of the services and their separate billing precluded aggregation for purposes of meeting the statutory threshold. The trial court and First Department both agreed with American Transit.

Jason Tenenbaum’s Analysis:

American Tr. Ins. Co. v Health Plus Surgery Ctr., LLC, 2021 NY Slip Op 01499 (1st Dept. 2021)

“Plaintiff is not entitled to de novo adjudication of the master arbitrator’s award in favor of defendant CitiMed Services, PA, because the award is less than $5,000 (Insurance Law § 5106). The medical services provided to plaintiff’s insured were separate and distinct from each other, were billed separately and should not be combined to meet the $5,000 threshold for de novo review (Imperium Ins. Co. v Innovative Chiropractic Servs., P.C., 43 Misc 3d 137 , 2014 NY Slip Op 50697 ).”

The biggest issue I have here is the citation to an Appellate Term case holding that Civil Court has jurisdiction over trial de novo-declaratory judgment actions. Under the current rules of the NY Court system, this is just wrong.

Legal Significance: The Anti-Manipulation Rule

The American Transit decision establishes an important anti-manipulation principle for Insurance Law section 5106(c) threshold calculations. Courts will examine the nature of the underlying medical services and how they were billed to determine whether aggregation is appropriate. Services that are separate and distinct, particularly when billed separately, cannot be artificially combined merely to reach the $5,000 threshold for trial de novo rights.

This holding protects the integrity of the two-tier dispute resolution system. If providers could freely combine unrelated services to manufacture jurisdiction for trial de novo proceedings, the $5,000 threshold would become meaningless. Every provider with multiple small claims could aggregate them to bypass the arbitration system’s finality provisions.

The decision requires courts to look beyond the total amount claimed and examine the substance of the dispute. Factors that may indicate separate and distinct services include: different dates of service, different treatment modalities, separate billing submissions, distinct CPT codes, and lack of medical relationship between procedures. When these factors demonstrate independence between services, courts should not permit aggregation.

However, the ruling leaves open the possibility that legitimately related services may be combined. When multiple services form part of a single treatment course, relate to the same injury, or were billed together as a package, providers may have stronger arguments for aggregation. The key distinction lies between genuine medical relationships versus artificial bundling for jurisdictional purposes.

Jason Tenenbaum correctly identifies a troubling aspect of the decision: the jurisdictional issue regarding whether Civil Court can properly hear trial de novo-declaratory judgment actions. This question has generated inconsistent rulings and creates uncertainty for practitioners selecting proper venues for these hybrid proceedings.

Practical Implications for No-Fault Practitioners

Medical providers contemplating arbitration appeals must carefully analyze whether their claims meet the $5,000 threshold without artificial manipulation. Providers should aggregate only those services that courts will view as genuinely related based on medical necessity, treatment continuity, and billing practices. Attempting to combine clearly separate services risks dismissal for lack of jurisdiction and may expose providers to sanctions for improper jurisdictional claims.

When multiple arbitration awards from the same insurer involve the same patient, providers should be particularly cautious about aggregation. Unless the services are medically and temporally related, courts will likely require each award to independently meet the threshold.

Insurance carriers facing trial de novo proceedings should scrutinize whether providers properly calculated the amount in controversy. When awards involve multiple distinct services that were separately billed, insurers should move to dismiss for lack of jurisdiction. This defense can eliminate costly litigation before substantive issues are reached.

Key Takeaway

Medical providers cannot circumvent the $5,000 threshold for appealing no-fault arbitration awards by combining separate, distinct medical services that were billed individually. Each service must independently meet the threshold requirement. This decision protects the arbitration system from manipulation while ensuring that only substantial disputes proceed to costly court proceedings.

Related Articles

• No-Fault attorney
• A limited collateral attack on an arbitration award is upheld
• $5.00 rule

Related: What “de novo” means in New York — trial de novo and de novo review, explained.